SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-22-000027
Filing Date
2022-03-24
Accepted
2022-03-24 16:12:26
Documents
45
Period of Report
2022-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K phas-20220324.htm   iXBRL 8-K 38630
2 EX-99.1 a20220323-phasebio_q42021f.htm EX-99.1 87229
3 EX-99.2 a2021q4financialsv202203.htm EX-99.2 34281
7 a2021q4financialsv202203001.jpg GRAPHIC 74164
8 a2021q4financialsv202203002.jpg GRAPHIC 228900
9 a2021q4financialsv202203003.jpg GRAPHIC 132077
10 a2021q4financialsv202203004.jpg GRAPHIC 127017
11 a2021q4financialsv202203005.jpg GRAPHIC 44419
12 a2021q4financialsv202203006.jpg GRAPHIC 135134
13 a2021q4financialsv202203007.jpg GRAPHIC 68889
14 a2021q4financialsv202203008.jpg GRAPHIC 55299
15 a2021q4financialsv202203009.jpg GRAPHIC 145235
16 a2021q4financialsv202203010.jpg GRAPHIC 84646
17 a2021q4financialsv202203011.jpg GRAPHIC 104672
18 a2021q4financialsv202203012.jpg GRAPHIC 118478
19 a2021q4financialsv202203013.jpg GRAPHIC 116623
20 a2021q4financialsv202203014.jpg GRAPHIC 100863
21 a2021q4financialsv202203015.jpg GRAPHIC 132732
22 a2021q4financialsv202203016.jpg GRAPHIC 100340
23 a2021q4financialsv202203017.jpg GRAPHIC 100747
24 a2021q4financialsv202203018.jpg GRAPHIC 75770
25 a2021q4financialsv202203019.jpg GRAPHIC 113208
26 a2021q4financialsv202203020.jpg GRAPHIC 112985
27 a2021q4financialsv202203021.jpg GRAPHIC 111858
28 a2021q4financialsv202203022.jpg GRAPHIC 92241
29 a2021q4financialsv202203023.jpg GRAPHIC 99974
30 a2021q4financialsv202203024.jpg GRAPHIC 140517
31 a2021q4financialsv202203025.jpg GRAPHIC 115715
32 a2021q4financialsv202203026.jpg GRAPHIC 93329
33 a2021q4financialsv202203027.jpg GRAPHIC 120998
34 a2021q4financialsv202203028.jpg GRAPHIC 56113
35 a2021q4financialsv202203029.jpg GRAPHIC 155647
36 a2021q4financialsv202203030.jpg GRAPHIC 132838
37 a2021q4financialsv202203031.jpg GRAPHIC 105486
  Complete submission text file 0001169245-22-000027.txt   5014025

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT phas-20220324.xsd EX-101.SCH 1914
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT phas-20220324_lab.xml EX-101.LAB 25998
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT phas-20220324_pre.xml EX-101.PRE 13731
39 EXTRACTED XBRL INSTANCE DOCUMENT phas-20220324_htm.xml XML 11441
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 22766612
SIC: 2834 Pharmaceutical Preparations